Literature DB >> 3096399

Mechanism of protein C-dependent clot lysis: role of plasminogen activator inhibitor.

Y Sakata, D J Loskutoff, C L Gladson, C M Hekman, J H Griffin.   

Abstract

The mechanism by which activated protein C stimulates fibrinolysis was studied in a simple radiolabeled clot lysis assay system containing purified tissue-type plasminogen activator, bovine endothelial plasminogen activator inhibitor (PAI), plasminogen, 125I-fibrinogen and thrombin. Fibrinolysis was greatly enhanced by the addition of purified bovine activated protein C; however, in the absence of PAI, activated protein C did not stimulate clot lysis, thus implicating this inhibitor in the mechanism. In clot lysis assay systems containing washed human platelets as a source of PAI, bovine-activated protein C-dependent fibrinolysis was associated with a marked decrease in PAI activity as detected using reverse fibrin autography. Bovine-activated protein C also decreased PAI activity of whole blood and of serum. In contrast to the bovine molecule, human-activated protein C was much less profibrinolytic in these clot lysis assay systems and much less potent in causing the neutralization of PAI. This species specificity of activated protein C in clot lysis assays reflect the known in vivo profibrinolytic species specificity. When purified bovine-activated protein C was mixed with purified PAI, complex formation was demonstrated using immunoblotting techniques after polyacrylamide gel electrophoresis in the presence of sodium dodecyl sulfate. These observations suggest that a major mechanism for bovine protein C-dependent fibrinolysis in in vitro clot lysis assays involves a direct neutralization of PAI by activated protein C.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3096399

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  23 in total

Review 1.  Coagulation in sepsis.

Authors:  André Amaral; Steven M Opal; Jean-Louis Vincent
Journal:  Intensive Care Med       Date:  2004-05-18       Impact factor: 17.440

2.  The effect of activated protein C on plasma cytokine levels in a porcine model of acute endotoxemia.

Authors:  Jeppe Sylvest Nielsen; Anders Larsson; Thomas Rix; Rasmus Nyboe; Jakob Gjedsted; Jan Krog; Thomas Ledet; Else Tønnesen
Journal:  Intensive Care Med       Date:  2007-04-25       Impact factor: 17.440

Review 3.  Regulation of the protein C anticoagulant and antiinflammatory pathways.

Authors:  A R Rezaie
Journal:  Curr Med Chem       Date:  2010       Impact factor: 4.530

4.  4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene in children with systemic meningococcaemia.

Authors:  Gotho Geishofer; Alexander Binder; Martin Müller; Bettina Zöhrer; Bernhard Resch; Wilhelm Müller; Jörg Faber; Adam Finn; Georg Endler; Christine Mannhalter; Werner Zenz
Journal:  Eur J Pediatr       Date:  2005-04-21       Impact factor: 3.183

5.  Thrombin-mediated activation of factor XI results in a thrombin-activatable fibrinolysis inhibitor-dependent inhibition of fibrinolysis.

Authors:  P A Von dem Borne; L Bajzar; J C Meijers; M E Nesheim; B N Bouma
Journal:  J Clin Invest       Date:  1997-05-15       Impact factor: 14.808

6.  Activated protein C inhibits local coagulation after intrapulmonary delivery of endotoxin in humans.

Authors:  Tom van der Poll; Marcel Levi; Jerry A Nick; Edward Abraham
Journal:  Am J Respir Crit Care Med       Date:  2005-03-04       Impact factor: 21.405

7.  Extrahepatic expression and regulation of protein C in the mouse.

Authors:  K Yamamoto; D J Loskutoff
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

8.  Activation of endothelial intrinsic NF-{kappa}B pathway impairs protein C anticoagulation mechanism and promotes coagulation in endotoxemic mice.

Authors:  Dongmei Song; Xiaobing Ye; Honglei Xu; Shu Fang Liu
Journal:  Blood       Date:  2009-07-20       Impact factor: 22.113

9.  The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression.

Authors:  B A Konkle; D Ginsburg
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

Review 10.  Acquired protein S deficiency.

Authors:  B Kemkes-Matthes
Journal:  Clin Investig       Date:  1992-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.